Group B streptococcal infection medical therapy
Group B Streptococcal Infection Microchapters |
Differentiating Group B Streptococcal Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Group B streptococcal infection medical therapy On the Web |
American Roentgen Ray Society Images of Group B streptococcal infection medical therapy |
Directions to Hospitals Treating Group B streptococcal infection |
Risk calculators and risk factors for Group B streptococcal infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Medical Therapy
Empirical Antibiotic Therapy in Neonatal Meningitis
GBS should be suspected as a causative agent for bacterial meningitis in infants less than two years of age for whom empirical antibiotic therapy should be initiated immediately.
Age | Possible pathogens causing the bacterial meningitis | Empirical treatment |
< 1 month | Streptococcus agalactiae Escherichia coli Listeria monocytogenes Klebsiella |
Ampicillin + cefotaxime OR Ampicillin + aminoglycoside |
1-23 months | Streptococcus pneumoniae Neisseria meningitidis Streptococcus agalactiae Haemophilus influenzae E. coli |
Vancomycin + third generation cephalosporin |